References
- Kraglund F, Jepsen P, Amanavicius N, et al. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. Scand J Gastroenterol. 2019;54(7):899–904.
- Ascha M, Abuqayyas S, Hanouneh I, et al. Predictors of mortality after transjugular portosystemic shunt. WJH. 2016;8(11):520–529.
- Zhang H, Pan JJ, Jiang XF, et al. Study of portal venous pressure gradient to predict high-hepatic encephalopathy-risk population post TIPS. Chin J Hepatol. 2021;29(1):72–74.
- Chen GH, Wang GC, Zhang CQ. Current status of research on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Clin Hepatol. 2021;37(5):1201–1204.
- Coronado WM, Ju C, Bullen J, et al. Predictors of occurrence and risk of hepatic encephalopathy after TIPS creation: a 15-year experience. Cardiovasc Intervent Radiol. 2020;43(8):1156–1164.
- Cao JW, Ding PX, Duan F, et al. CCI clinical practice guidelines: management of TIPS for portal hypertension (2019 edition). J Clin Hepatol. 2019;35(12):2694–2699.
- Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007;41(Suppl 3):S344–351.
- Yang WS, Guo WH. Correlation between liver hemodynamic indicators and portal vein pressure in patients with cirrhotic portal hypertension. Chinese Gen Pract. 2016;19(23):2784–2788.
- Li MY, Zhou XQ. Research progress on pathogenesis of hepatic encephalopathy. Chinese J Gastroenterol. 2020;25(2):116–120.
- Inchingolo R, Posa A, Mariappan M, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review. World J Gastroenterol. 2020;26(34):5060–5073.
- Tabchouri N, Barbier L, Menahem B, et al. Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients. J Gastrointest Surg. 2019;23(12):2383–2390.
- Li YL, Pang HJ, He XF. Establishment and validation of nomogram in patients with early hepatic encephalopathy after TIPS. J Pract Med. 2020;36(7):963–968.
- Sarwar A, Esparaz AM, Chakrala N, et al. Efficacy of TIPS reduction for refractory hepatic encephalopathy, right heart failure, and liver dysfunction. Am J Roentgenol. 2021;216(5):1267–1272.
- Zhong B, Wang W, Shen J, et al. Single-centre retrospective training cohort using artificial intelligence for prognostic prediction of encephalopathy, mortality, and liver dysfunction after early TIPS creation. Cardiovasc Intervent Radiol. 2021;44(10):1597–1608.
- Pinter SZ, Rubin JM, Kripfgans OD, et al. Volumetric blood flow in transjugular intrahepatic portosystemic shunt revision using 3-dimensional doppler sonography. J Ultrasound Med. 2015;34(2):257–266.
- Li Y, He X, Pang H. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt. Turk J Gastroenterol. 2019;30(8):702–707.
- Vizzutti F, Schepis F, Arena U, et al. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med. 2020;15(1):37–48.
- Rowley MW, Choi M, Chen S, et al. Refractory hepatic encephalopathy after elective transjugular intrahepatic portosystemic shunt: Risk factors and outcomes with revision. Cardiovasc Intervent Radiol. 2018;41(11):1765–1772.